Chairside Mouthrinse Test and Cost Effectiveness (JuvePar)
Primary Purpose
Periodontitis, Juvenile
Status
Unknown status
Phase
Not Applicable
Locations
Finland
Study Type
Interventional
Intervention
aMMP-8 chairside test
Sponsored by
About this trial
This is an interventional diagnostic trial for Periodontitis, Juvenile
Eligibility Criteria
Inclusion Criteria:
- All 8 class (aged 14-15 years) pupils in Jukola, Hämeenlinna, Finland
- Written informed consent from the participants and their parents (one of them)
Exclusion Criteria:
- No written consent to the study
Sites / Locations
- Anna Maria Heikkinen
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
No Intervention
Arm Label
aMMP-8 chairside test
No test
Arm Description
Test group. The aMMP-8 chairside mouth rinse test is performed for the test group.It identifies adolescents with poor oral hygiene at risk for subclinical periodontitis without detectable and visible manifestations of the illness, such as periodontal deepened pockets.
The other group is control group. No test administered.
Outcomes
Primary Outcome Measures
aMMP-8 test
Mouth rinse samples are analysed by method for chair-side diagnostic testing: the aMMP-8 specific lateral-flow point-of-care (PoC)/chair-side test (PerioSafe®, Dentognostics GmbH, Jena, Germany). The result is provided in 5 minutes and is graded by eye as positive or negative. One line means that the test is negative but successfully done and two lines the test is positive.
Secondary Outcome Measures
Full Information
NCT ID
NCT04139863
First Posted
October 7, 2019
Last Updated
November 2, 2020
Sponsor
University of Helsinki
1. Study Identification
Unique Protocol Identification Number
NCT04139863
Brief Title
Chairside Mouthrinse Test and Cost Effectiveness
Acronym
JuvePar
Official Title
Pilot Study on Oral Health Status Chairside Mouthrinse Test in Finnish Adolescents and Cost Effectiveness of the Test
Study Type
Interventional
2. Study Status
Record Verification Date
November 2020
Overall Recruitment Status
Unknown status
Study Start Date
September 1, 2017 (Actual)
Primary Completion Date
November 2, 2020 (Anticipated)
Study Completion Date
November 2, 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Helsinki
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim is to study whether participants at risk could be identified using an aMMP-8 chairside mouth rinse test and to study if oral health and health behaviour is linked to the test result in Finnish adolescents.
Detailed Description
Adolescents (14-15-year-olds) are randomly divided to control group and test group. Chairside mouth rinse test for aMMP-8 is performed for the test group. Two groups are compared with each other.
Participants are asked to fill a questionnaire which consists of questions concerning oral hygiene habits, tobacco products, alcohol, drug and snuff use.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Periodontitis, Juvenile
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
200 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
aMMP-8 chairside test
Arm Type
Other
Arm Description
Test group. The aMMP-8 chairside mouth rinse test is performed for the test group.It identifies adolescents with poor oral hygiene at risk for subclinical periodontitis without detectable and visible manifestations of the illness, such as periodontal deepened pockets.
Arm Title
No test
Arm Type
No Intervention
Arm Description
The other group is control group. No test administered.
Intervention Type
Diagnostic Test
Intervention Name(s)
aMMP-8 chairside test
Other Intervention Name(s)
No test
Intervention Description
No test
Primary Outcome Measure Information:
Title
aMMP-8 test
Description
Mouth rinse samples are analysed by method for chair-side diagnostic testing: the aMMP-8 specific lateral-flow point-of-care (PoC)/chair-side test (PerioSafe®, Dentognostics GmbH, Jena, Germany). The result is provided in 5 minutes and is graded by eye as positive or negative. One line means that the test is negative but successfully done and two lines the test is positive.
Time Frame
1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
14 Years
Maximum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
All 8 class (aged 14-15 years) pupils in Jukola, Hämeenlinna, Finland
Written informed consent from the participants and their parents (one of them)
Exclusion Criteria:
No written consent to the study
Facility Information:
Facility Name
Anna Maria Heikkinen
City
Helsinki
State/Province
Helsinki University
ZIP/Postal Code
FI-00014
Country
Finland
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Chairside Mouthrinse Test and Cost Effectiveness
We'll reach out to this number within 24 hrs